| Multi-omics integration to identify the genetic expression and protein signature of dilated and ischemic cardiomyopathy K Portokallidou, N Dovrolis, G Ragia, N Atzemian, G Kolios, ... Frontiers in Cardiovascular Medicine 10, 1115623, 2023 | 10 | 2023 |
| Therapeutic Drug Monitoring (TDM) Implementation in Public Hospitals in Greece in 2003 and 2021: A Comparative Analysis of TDM Evolution over the Years G Voulgaridou, T Paraskeva, G Ragia, N Atzemian, K Portokallidou, ... Pharmaceutics 15 (9), 2181, 2023 | 2 | 2023 |
| Insights into type 2 diabetes mellitus in atrial fibrillation patients: a proteomics approach N Atzemian, V Androutsopoulou, K Portokallidou, G Leonidis, ... European Heart Journal 45 (Supplement_1), ehae666. 446, 2024 | | 2024 |
| Beyond the Rhythm: In Silico Identification of Key Genes and Therapeutic Targets in Atrial Fibrillation N Atzemian, N Dovrolis, G Ragia, K Portokallidou, G Kolios, ... Biomedicines 11 (10), 2632, 2023 | | 2023 |
| Elucidating the biological and pharmacological background of two Heart Failure subtypes, Dilated and Ischemic Cardiomyopathy; a multi-omics bioinformatics approach K Portokallidou, N Dovrolis, G Ragia, G Kolios, V Manolopoulos EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY 78 (SUPPL 1), S34-S34, 2022 | | 2022 |
Vangelis ManolopoulosProfessor of Pharmacology, Pharmacogenomics, and Precision Medicine, Democritus University of Thrace在 med.duth.gr 的电子邮件经过验证
